nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—CYP3A4—breast cancer	0.0875	0.546	CbGaD
Fentanyl—ABCB1—breast cancer	0.0728	0.454	CbGaD
Fentanyl—Loperamide—Toremifene—breast cancer	0.0438	0.136	CrCrCtD
Fentanyl—Phenoxybenzamine—Toremifene—breast cancer	0.0359	0.111	CrCrCtD
Fentanyl—Dextropropoxyphene—Toremifene—breast cancer	0.0359	0.111	CrCrCtD
Fentanyl—Loperamide—Tamoxifen—breast cancer	0.0275	0.0853	CrCrCtD
Fentanyl—Benzphetamine—Toremifene—breast cancer	0.0251	0.078	CrCrCtD
Fentanyl—Benzyl Benzoate—Toremifene—breast cancer	0.0233	0.0723	CrCrCtD
Fentanyl—Dextropropoxyphene—Tamoxifen—breast cancer	0.0226	0.07	CrCrCtD
Fentanyl—Phenoxybenzamine—Tamoxifen—breast cancer	0.0226	0.07	CrCrCtD
Fentanyl—Diphenhydramine—Toremifene—breast cancer	0.0223	0.0693	CrCrCtD
Fentanyl—Methadone—Tamoxifen—breast cancer	0.0189	0.0586	CrCrCtD
Fentanyl—CYP3A5—Lapatinib—breast cancer	0.0189	0.0605	CbGbCtD
Fentanyl—ABCB1—Toremifene—breast cancer	0.0168	0.054	CbGbCtD
Fentanyl—Benzphetamine—Tamoxifen—breast cancer	0.0158	0.049	CrCrCtD
Fentanyl—Benzyl Benzoate—Tamoxifen—breast cancer	0.0146	0.0454	CrCrCtD
Fentanyl—CYP3A4—Exemestane—breast cancer	0.0146	0.0467	CbGbCtD
Fentanyl—Diphenhydramine—Tamoxifen—breast cancer	0.014	0.0435	CrCrCtD
Fentanyl—CYP3A7—Tamoxifen—breast cancer	0.0126	0.0404	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.0126	0.0404	CbGbCtD
Fentanyl—CYP3A4—Letrozole—breast cancer	0.0124	0.0397	CbGbCtD
Fentanyl—ABCB1—Lapatinib—breast cancer	0.0123	0.0394	CbGbCtD
Fentanyl—CYP3A4—Anastrozole—breast cancer	0.011	0.0354	CbGbCtD
Fentanyl—CYP3A4—Toremifene—breast cancer	0.0101	0.0324	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.0098	0.0315	CbGbCtD
Fentanyl—CYP3A7—Paclitaxel—breast cancer	0.0098	0.0315	CbGbCtD
Fentanyl—CYP3A7—Irinotecan—breast cancer	0.00967	0.031	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.00967	0.031	CbGbCtD
Fentanyl—CYP3A5—Tamoxifen—breast cancer	0.00945	0.0303	CbGbCtD
Fentanyl—CYP3A4—Fulvestrant—breast cancer	0.00938	0.0301	CbGbCtD
Fentanyl—CYP3A4—Thiotepa—breast cancer	0.00836	0.0268	CbGbCtD
Fentanyl—CYP3A4—Ixabepilone—breast cancer	0.00764	0.0245	CbGbCtD
Fentanyl—CYP3A4—Lapatinib—breast cancer	0.00736	0.0236	CbGbCtD
Fentanyl—CYP3A5—Paclitaxel—breast cancer	0.00735	0.0236	CbGbCtD
Fentanyl—CYP3A5—Irinotecan—breast cancer	0.00726	0.0233	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.00709	0.0227	CbGbCtD
Fentanyl—CYP3A7—Docetaxel—breast cancer	0.00709	0.0227	CbGbCtD
Fentanyl—ABCB1—Vinorelbine—breast cancer	0.00681	0.0219	CbGbCtD
Fentanyl—ABCB1—Tamoxifen—breast cancer	0.00615	0.0197	CbGbCtD
Fentanyl—ABCB1—Mitoxantrone—breast cancer	0.006	0.0192	CbGbCtD
Fentanyl—CYP3A4—Raloxifene—breast cancer	0.00558	0.0179	CbGbCtD
Fentanyl—CYP3A5—Docetaxel—breast cancer	0.00532	0.0171	CbGbCtD
Fentanyl—ABCB1—Gemcitabine—breast cancer	0.0053	0.017	CbGbCtD
Fentanyl—ABCB1—Paclitaxel—breast cancer	0.00479	0.0154	CbGbCtD
Fentanyl—ABCB1—Irinotecan—breast cancer	0.00472	0.0151	CbGbCtD
Fentanyl—ABCB1—Vinblastine—breast cancer	0.0042	0.0135	CbGbCtD
Fentanyl—CYP3A4—Vinorelbine—breast cancer	0.00408	0.0131	CbGbCtD
Fentanyl—CYP3A4—Tamoxifen—breast cancer	0.00368	0.0118	CbGbCtD
Fentanyl—CYP3A4—Mitoxantrone—breast cancer	0.00359	0.0115	CbGbCtD
Fentanyl—ABCB1—Docetaxel—breast cancer	0.00346	0.0111	CbGbCtD
Fentanyl—CYP3A4—Paclitaxel—breast cancer	0.00287	0.0092	CbGbCtD
Fentanyl—CYP3A4—Irinotecan—breast cancer	0.00283	0.00908	CbGbCtD
Fentanyl—ABCB1—Doxorubicin—breast cancer	0.00258	0.00828	CbGbCtD
Fentanyl—CYP3A4—Vinblastine—breast cancer	0.00252	0.00807	CbGbCtD
Fentanyl—ABCB1—Methotrexate—breast cancer	0.0025	0.00802	CbGbCtD
Fentanyl—CYP3A4—Docetaxel—breast cancer	0.00207	0.00665	CbGbCtD
Fentanyl—CYP3A4—Doxorubicin—breast cancer	0.00155	0.00496	CbGbCtD
Fentanyl—Fexofenadine—SLCO1B1—breast cancer	0.000229	0.104	CrCbGaD
Fentanyl—Benazepril—MTHFR—breast cancer	0.000155	0.0702	CrCbGaD
Fentanyl—Trimethaphan—BCHE—breast cancer	0.00015	0.068	CrCbGaD
Fentanyl—Sufentanil—CYP3A4—breast cancer	9.69e-05	0.0438	CrCbGaD
Fentanyl—Alfentanil—CYP3A4—breast cancer	9.01e-05	0.0408	CrCbGaD
Fentanyl—Astemizole—CYP2D6—breast cancer	8.17e-05	0.037	CrCbGaD
Fentanyl—Alfentanil—ALB—breast cancer	7.86e-05	0.0356	CrCbGaD
Fentanyl—Alfentanil—ABCB1—breast cancer	7.5e-05	0.0339	CrCbGaD
Fentanyl—Phenylbutazone—PTGS1—breast cancer	7.38e-05	0.0334	CrCbGaD
Fentanyl—Astemizole—CYP3A4—breast cancer	7.01e-05	0.0317	CrCbGaD
Fentanyl—Aprindine—CYP2D6—breast cancer	6.77e-05	0.0306	CrCbGaD
Fentanyl—Darifenacin—CYP2D6—breast cancer	5.99e-05	0.0271	CrCbGaD
Fentanyl—Astemizole—ABCB1—breast cancer	5.83e-05	0.0264	CrCbGaD
Fentanyl—Fexofenadine—CYP2D6—breast cancer	5.82e-05	0.0263	CrCbGaD
Fentanyl—Benzatropine—CYP2D6—breast cancer	5.31e-05	0.024	CrCbGaD
Fentanyl—Darifenacin—CYP3A4—breast cancer	5.13e-05	0.0232	CrCbGaD
Fentanyl—Methadone—CYP19A1—breast cancer	4.82e-05	0.0218	CrCbGaD
Fentanyl—Propafenone—CYP2D6—breast cancer	4.69e-05	0.0212	CrCbGaD
Fentanyl—Phenylbutazone—CYP3A4—breast cancer	4.31e-05	0.0195	CrCbGaD
Fentanyl—Phenylbutazone—PTGS2—breast cancer	4.22e-05	0.0191	CrCbGaD
Fentanyl—Bepridil—CYP2D6—breast cancer	4.18e-05	0.0189	CrCbGaD
Fentanyl—Fexofenadine—ABCB1—breast cancer	4.16e-05	0.0188	CrCbGaD
Fentanyl—Propafenone—CYP3A4—breast cancer	4.03e-05	0.0182	CrCbGaD
Fentanyl—Diphenhydramine—PTGS1—breast cancer	4.01e-05	0.0182	CrCbGaD
Fentanyl—Dextropropoxyphene—CYP2D6—breast cancer	3.89e-05	0.0176	CrCbGaD
Fentanyl—Loperamide—CYP2D6—breast cancer	3.71e-05	0.0168	CrCbGaD
Fentanyl—Modafinil—CYP3A4—breast cancer	3.37e-05	0.0153	CrCbGaD
Fentanyl—Propafenone—ABCB1—breast cancer	3.35e-05	0.0152	CrCbGaD
Fentanyl—Dextropropoxyphene—CYP3A4—breast cancer	3.34e-05	0.0151	CrCbGaD
Fentanyl—Loperamide—CYP3A4—breast cancer	3.18e-05	0.0144	CrCbGaD
Fentanyl—Bepridil—ABCB1—breast cancer	2.99e-05	0.0135	CrCbGaD
Fentanyl—Benzphetamine—CYP3A4—breast cancer	2.92e-05	0.0132	CrCbGaD
Fentanyl—Phenoxybenzamine—CYP3A4—breast cancer	2.8e-05	0.0126	CrCbGaD
Fentanyl—Diphenhydramine—CYP2D6—breast cancer	2.73e-05	0.0124	CrCbGaD
Fentanyl—Loperamide—ABCB1—breast cancer	2.65e-05	0.012	CrCbGaD
Fentanyl—Methadone—CYP2D6—breast cancer	2.64e-05	0.0119	CrCbGaD
Fentanyl—Methadone—CYP3A4—breast cancer	2.26e-05	0.0102	CrCbGaD
Fentanyl—Methadone—ABCB1—breast cancer	1.88e-05	0.00852	CrCbGaD
Fentanyl—Urethral disorder—Doxorubicin—breast cancer	1.28e-05	7.98e-05	CcSEcCtD
Fentanyl—Nausea—Mitoxantrone—breast cancer	1.28e-05	7.97e-05	CcSEcCtD
Fentanyl—Nausea—Irinotecan—breast cancer	1.28e-05	7.97e-05	CcSEcCtD
Fentanyl—Immune system disorder—Epirubicin—breast cancer	1.28e-05	7.95e-05	CcSEcCtD
Fentanyl—Mediastinal disorder—Epirubicin—breast cancer	1.28e-05	7.93e-05	CcSEcCtD
Fentanyl—Pain—Docetaxel—breast cancer	1.27e-05	7.93e-05	CcSEcCtD
Fentanyl—Constipation—Docetaxel—breast cancer	1.27e-05	7.93e-05	CcSEcCtD
Fentanyl—Back pain—Methotrexate—breast cancer	1.27e-05	7.92e-05	CcSEcCtD
Fentanyl—Dyspepsia—Capecitabine—breast cancer	1.27e-05	7.9e-05	CcSEcCtD
Fentanyl—Chills—Epirubicin—breast cancer	1.27e-05	7.9e-05	CcSEcCtD
Fentanyl—Arrhythmia—Epirubicin—breast cancer	1.26e-05	7.86e-05	CcSEcCtD
Fentanyl—Visual impairment—Doxorubicin—breast cancer	1.26e-05	7.85e-05	CcSEcCtD
Fentanyl—Asthenia—Paclitaxel—breast cancer	1.26e-05	7.85e-05	CcSEcCtD
Fentanyl—Decreased appetite—Capecitabine—breast cancer	1.25e-05	7.8e-05	CcSEcCtD
Fentanyl—Alopecia—Epirubicin—breast cancer	1.25e-05	7.78e-05	CcSEcCtD
Fentanyl—Nausea—Gemcitabine—breast cancer	1.25e-05	7.76e-05	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Capecitabine—breast cancer	1.25e-05	7.75e-05	CcSEcCtD
Fentanyl—Fatigue—Capecitabine—breast cancer	1.24e-05	7.74e-05	CcSEcCtD
Fentanyl—Pruritus—Paclitaxel—breast cancer	1.24e-05	7.74e-05	CcSEcCtD
Fentanyl—Vision blurred—Methotrexate—breast cancer	1.24e-05	7.72e-05	CcSEcCtD
Fentanyl—Mental disorder—Epirubicin—breast cancer	1.24e-05	7.71e-05	CcSEcCtD
Fentanyl—Erythema multiforme—Doxorubicin—breast cancer	1.24e-05	7.7e-05	CcSEcCtD
Fentanyl—Pain—Capecitabine—breast cancer	1.23e-05	7.68e-05	CcSEcCtD
Fentanyl—Constipation—Capecitabine—breast cancer	1.23e-05	7.68e-05	CcSEcCtD
Fentanyl—Malnutrition—Epirubicin—breast cancer	1.23e-05	7.66e-05	CcSEcCtD
Fentanyl—Erythema—Epirubicin—breast cancer	1.23e-05	7.66e-05	CcSEcCtD
Fentanyl—Feeling abnormal—Docetaxel—breast cancer	1.23e-05	7.64e-05	CcSEcCtD
Fentanyl—Nausea—Fluorouracil—breast cancer	1.23e-05	7.63e-05	CcSEcCtD
Fentanyl—Eye disorder—Doxorubicin—breast cancer	1.22e-05	7.61e-05	CcSEcCtD
Fentanyl—Ill-defined disorder—Methotrexate—breast cancer	1.22e-05	7.6e-05	CcSEcCtD
Fentanyl—Tinnitus—Doxorubicin—breast cancer	1.22e-05	7.59e-05	CcSEcCtD
Fentanyl—Gastrointestinal pain—Docetaxel—breast cancer	1.22e-05	7.58e-05	CcSEcCtD
Fentanyl—Anaemia—Methotrexate—breast cancer	1.22e-05	7.57e-05	CcSEcCtD
Fentanyl—Cardiac disorder—Doxorubicin—breast cancer	1.21e-05	7.56e-05	CcSEcCtD
Fentanyl—Flushing—Doxorubicin—breast cancer	1.21e-05	7.56e-05	CcSEcCtD
Fentanyl—Flatulence—Epirubicin—breast cancer	1.21e-05	7.55e-05	CcSEcCtD
Fentanyl—Tension—Epirubicin—breast cancer	1.21e-05	7.52e-05	CcSEcCtD
Fentanyl—Dysgeusia—Epirubicin—breast cancer	1.21e-05	7.5e-05	CcSEcCtD
Fentanyl—Diarrhoea—Paclitaxel—breast cancer	1.2e-05	7.48e-05	CcSEcCtD
Fentanyl—Nervousness—Epirubicin—breast cancer	1.2e-05	7.44e-05	CcSEcCtD
Fentanyl—Back pain—Epirubicin—breast cancer	1.19e-05	7.41e-05	CcSEcCtD
Fentanyl—Feeling abnormal—Capecitabine—breast cancer	1.19e-05	7.4e-05	CcSEcCtD
Fentanyl—Angiopathy—Doxorubicin—breast cancer	1.19e-05	7.39e-05	CcSEcCtD
Fentanyl—Malaise—Methotrexate—breast cancer	1.19e-05	7.38e-05	CcSEcCtD
Fentanyl—Muscle spasms—Epirubicin—breast cancer	1.18e-05	7.37e-05	CcSEcCtD
Fentanyl—Immune system disorder—Doxorubicin—breast cancer	1.18e-05	7.36e-05	CcSEcCtD
Fentanyl—Vertigo—Methotrexate—breast cancer	1.18e-05	7.36e-05	CcSEcCtD
Fentanyl—Gastrointestinal pain—Capecitabine—breast cancer	1.18e-05	7.34e-05	CcSEcCtD
Fentanyl—Mediastinal disorder—Doxorubicin—breast cancer	1.18e-05	7.34e-05	CcSEcCtD
Fentanyl—Abdominal pain—Docetaxel—breast cancer	1.18e-05	7.33e-05	CcSEcCtD
Fentanyl—Body temperature increased—Docetaxel—breast cancer	1.18e-05	7.33e-05	CcSEcCtD
Fentanyl—Leukopenia—Methotrexate—breast cancer	1.18e-05	7.33e-05	CcSEcCtD
Fentanyl—Chills—Doxorubicin—breast cancer	1.17e-05	7.31e-05	CcSEcCtD
Fentanyl—Arrhythmia—Doxorubicin—breast cancer	1.17e-05	7.28e-05	CcSEcCtD
Fentanyl—Dizziness—Paclitaxel—breast cancer	1.16e-05	7.23e-05	CcSEcCtD
Fentanyl—Vision blurred—Epirubicin—breast cancer	1.16e-05	7.22e-05	CcSEcCtD
Fentanyl—Alopecia—Doxorubicin—breast cancer	1.16e-05	7.2e-05	CcSEcCtD
Fentanyl—Cough—Methotrexate—breast cancer	1.15e-05	7.14e-05	CcSEcCtD
Fentanyl—Mental disorder—Doxorubicin—breast cancer	1.15e-05	7.14e-05	CcSEcCtD
Fentanyl—Urticaria—Capecitabine—breast cancer	1.15e-05	7.13e-05	CcSEcCtD
Fentanyl—Ill-defined disorder—Epirubicin—breast cancer	1.14e-05	7.11e-05	CcSEcCtD
Fentanyl—Abdominal pain—Capecitabine—breast cancer	1.14e-05	7.1e-05	CcSEcCtD
Fentanyl—Body temperature increased—Capecitabine—breast cancer	1.14e-05	7.1e-05	CcSEcCtD
Fentanyl—Convulsion—Methotrexate—breast cancer	1.14e-05	7.09e-05	CcSEcCtD
Fentanyl—Malnutrition—Doxorubicin—breast cancer	1.14e-05	7.09e-05	CcSEcCtD
Fentanyl—Erythema—Doxorubicin—breast cancer	1.14e-05	7.09e-05	CcSEcCtD
Fentanyl—Anaemia—Epirubicin—breast cancer	1.14e-05	7.08e-05	CcSEcCtD
Fentanyl—Agitation—Epirubicin—breast cancer	1.13e-05	7.04e-05	CcSEcCtD
Fentanyl—Flatulence—Doxorubicin—breast cancer	1.12e-05	6.99e-05	CcSEcCtD
Fentanyl—Arthralgia—Methotrexate—breast cancer	1.12e-05	6.97e-05	CcSEcCtD
Fentanyl—Chest pain—Methotrexate—breast cancer	1.12e-05	6.97e-05	CcSEcCtD
Fentanyl—Myalgia—Methotrexate—breast cancer	1.12e-05	6.97e-05	CcSEcCtD
Fentanyl—Tension—Doxorubicin—breast cancer	1.12e-05	6.96e-05	CcSEcCtD
Fentanyl—Vomiting—Paclitaxel—breast cancer	1.12e-05	6.95e-05	CcSEcCtD
Fentanyl—Dysgeusia—Doxorubicin—breast cancer	1.12e-05	6.94e-05	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.11e-05	6.92e-05	CcSEcCtD
Fentanyl—Malaise—Epirubicin—breast cancer	1.11e-05	6.91e-05	CcSEcCtD
Fentanyl—Rash—Paclitaxel—breast cancer	1.11e-05	6.9e-05	CcSEcCtD
Fentanyl—Dermatitis—Paclitaxel—breast cancer	1.11e-05	6.89e-05	CcSEcCtD
Fentanyl—Discomfort—Methotrexate—breast cancer	1.11e-05	6.89e-05	CcSEcCtD
Fentanyl—Nervousness—Doxorubicin—breast cancer	1.11e-05	6.89e-05	CcSEcCtD
Fentanyl—Vertigo—Epirubicin—breast cancer	1.11e-05	6.88e-05	CcSEcCtD
Fentanyl—Syncope—Epirubicin—breast cancer	1.1e-05	6.87e-05	CcSEcCtD
Fentanyl—Leukopenia—Epirubicin—breast cancer	1.1e-05	6.86e-05	CcSEcCtD
Fentanyl—Back pain—Doxorubicin—breast cancer	1.1e-05	6.86e-05	CcSEcCtD
Fentanyl—Headache—Paclitaxel—breast cancer	1.1e-05	6.85e-05	CcSEcCtD
Fentanyl—Hypersensitivity—Docetaxel—breast cancer	1.1e-05	6.83e-05	CcSEcCtD
Fentanyl—Muscle spasms—Doxorubicin—breast cancer	1.1e-05	6.82e-05	CcSEcCtD
Fentanyl—Palpitations—Epirubicin—breast cancer	1.09e-05	6.77e-05	CcSEcCtD
Fentanyl—Confusional state—Methotrexate—breast cancer	1.08e-05	6.74e-05	CcSEcCtD
Fentanyl—Loss of consciousness—Epirubicin—breast cancer	1.08e-05	6.73e-05	CcSEcCtD
Fentanyl—Cough—Epirubicin—breast cancer	1.07e-05	6.69e-05	CcSEcCtD
Fentanyl—Anaphylactic shock—Methotrexate—breast cancer	1.07e-05	6.68e-05	CcSEcCtD
Fentanyl—Vision blurred—Doxorubicin—breast cancer	1.07e-05	6.68e-05	CcSEcCtD
Fentanyl—Asthenia—Docetaxel—breast cancer	1.07e-05	6.65e-05	CcSEcCtD
Fentanyl—Convulsion—Epirubicin—breast cancer	1.07e-05	6.64e-05	CcSEcCtD
Fentanyl—Infection—Methotrexate—breast cancer	1.07e-05	6.64e-05	CcSEcCtD
Fentanyl—Hypertension—Epirubicin—breast cancer	1.06e-05	6.62e-05	CcSEcCtD
Fentanyl—Hypersensitivity—Capecitabine—breast cancer	1.06e-05	6.61e-05	CcSEcCtD
Fentanyl—Ill-defined disorder—Doxorubicin—breast cancer	1.06e-05	6.58e-05	CcSEcCtD
Fentanyl—Pruritus—Docetaxel—breast cancer	1.05e-05	6.56e-05	CcSEcCtD
Fentanyl—Nervous system disorder—Methotrexate—breast cancer	1.05e-05	6.55e-05	CcSEcCtD
Fentanyl—Anaemia—Doxorubicin—breast cancer	1.05e-05	6.55e-05	CcSEcCtD
Fentanyl—Thrombocytopenia—Methotrexate—breast cancer	1.05e-05	6.54e-05	CcSEcCtD
Fentanyl—Myalgia—Epirubicin—breast cancer	1.05e-05	6.52e-05	CcSEcCtD
Fentanyl—Chest pain—Epirubicin—breast cancer	1.05e-05	6.52e-05	CcSEcCtD
Fentanyl—Arthralgia—Epirubicin—breast cancer	1.05e-05	6.52e-05	CcSEcCtD
Fentanyl—Agitation—Doxorubicin—breast cancer	1.05e-05	6.52e-05	CcSEcCtD
Fentanyl—Anxiety—Epirubicin—breast cancer	1.04e-05	6.5e-05	CcSEcCtD
Fentanyl—Nausea—Paclitaxel—breast cancer	1.04e-05	6.5e-05	CcSEcCtD
Fentanyl—Skin disorder—Methotrexate—breast cancer	1.04e-05	6.49e-05	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.04e-05	6.48e-05	CcSEcCtD
Fentanyl—Hyperhidrosis—Methotrexate—breast cancer	1.04e-05	6.46e-05	CcSEcCtD
Fentanyl—Discomfort—Epirubicin—breast cancer	1.04e-05	6.45e-05	CcSEcCtD
Fentanyl—Asthenia—Capecitabine—breast cancer	1.04e-05	6.44e-05	CcSEcCtD
Fentanyl—Malaise—Doxorubicin—breast cancer	1.03e-05	6.39e-05	CcSEcCtD
Fentanyl—Dry mouth—Epirubicin—breast cancer	1.03e-05	6.38e-05	CcSEcCtD
Fentanyl—Vertigo—Doxorubicin—breast cancer	1.02e-05	6.37e-05	CcSEcCtD
Fentanyl—Anorexia—Methotrexate—breast cancer	1.02e-05	6.37e-05	CcSEcCtD
Fentanyl—Syncope—Doxorubicin—breast cancer	1.02e-05	6.36e-05	CcSEcCtD
Fentanyl—Pruritus—Capecitabine—breast cancer	1.02e-05	6.35e-05	CcSEcCtD
Fentanyl—Leukopenia—Doxorubicin—breast cancer	1.02e-05	6.35e-05	CcSEcCtD
Fentanyl—Diarrhoea—Docetaxel—breast cancer	1.02e-05	6.34e-05	CcSEcCtD
Fentanyl—Confusional state—Epirubicin—breast cancer	1.01e-05	6.31e-05	CcSEcCtD
Fentanyl—Palpitations—Doxorubicin—breast cancer	1.01e-05	6.27e-05	CcSEcCtD
Fentanyl—Oedema—Epirubicin—breast cancer	1.01e-05	6.25e-05	CcSEcCtD
Fentanyl—Anaphylactic shock—Epirubicin—breast cancer	1.01e-05	6.25e-05	CcSEcCtD
Fentanyl—Hypotension—Methotrexate—breast cancer	1e-05	6.24e-05	CcSEcCtD
Fentanyl—Loss of consciousness—Doxorubicin—breast cancer	1e-05	6.23e-05	CcSEcCtD
Fentanyl—Infection—Epirubicin—breast cancer	9.99e-06	6.21e-05	CcSEcCtD
Fentanyl—Cough—Doxorubicin—breast cancer	9.94e-06	6.19e-05	CcSEcCtD
Fentanyl—Shock—Epirubicin—breast cancer	9.89e-06	6.15e-05	CcSEcCtD
Fentanyl—Convulsion—Doxorubicin—breast cancer	9.87e-06	6.14e-05	CcSEcCtD
Fentanyl—Diarrhoea—Capecitabine—breast cancer	9.87e-06	6.14e-05	CcSEcCtD
Fentanyl—Nervous system disorder—Epirubicin—breast cancer	9.86e-06	6.13e-05	CcSEcCtD
Fentanyl—Dizziness—Docetaxel—breast cancer	9.85e-06	6.13e-05	CcSEcCtD
Fentanyl—Thrombocytopenia—Epirubicin—breast cancer	9.84e-06	6.12e-05	CcSEcCtD
Fentanyl—Hypertension—Doxorubicin—breast cancer	9.84e-06	6.12e-05	CcSEcCtD
Fentanyl—Tachycardia—Epirubicin—breast cancer	9.81e-06	6.1e-05	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Methotrexate—breast cancer	9.79e-06	6.09e-05	CcSEcCtD
Fentanyl—Skin disorder—Epirubicin—breast cancer	9.76e-06	6.07e-05	CcSEcCtD
Fentanyl—Hyperhidrosis—Epirubicin—breast cancer	9.72e-06	6.05e-05	CcSEcCtD
Fentanyl—Insomnia—Methotrexate—breast cancer	9.72e-06	6.04e-05	CcSEcCtD
Fentanyl—Arthralgia—Doxorubicin—breast cancer	9.7e-06	6.04e-05	CcSEcCtD
Fentanyl—Chest pain—Doxorubicin—breast cancer	9.7e-06	6.04e-05	CcSEcCtD
Fentanyl—Myalgia—Doxorubicin—breast cancer	9.7e-06	6.04e-05	CcSEcCtD
Fentanyl—Anxiety—Doxorubicin—breast cancer	9.67e-06	6.02e-05	CcSEcCtD
Fentanyl—Paraesthesia—Methotrexate—breast cancer	9.65e-06	6e-05	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	9.64e-06	5.99e-05	CcSEcCtD
Fentanyl—Discomfort—Doxorubicin—breast cancer	9.59e-06	5.96e-05	CcSEcCtD
Fentanyl—Anorexia—Epirubicin—breast cancer	9.58e-06	5.96e-05	CcSEcCtD
Fentanyl—Dyspnoea—Methotrexate—breast cancer	9.58e-06	5.96e-05	CcSEcCtD
Fentanyl—Somnolence—Methotrexate—breast cancer	9.55e-06	5.94e-05	CcSEcCtD
Fentanyl—Dizziness—Capecitabine—breast cancer	9.54e-06	5.94e-05	CcSEcCtD
Fentanyl—Dry mouth—Doxorubicin—breast cancer	9.49e-06	5.9e-05	CcSEcCtD
Fentanyl—Vomiting—Docetaxel—breast cancer	9.48e-06	5.89e-05	CcSEcCtD
Fentanyl—Dyspepsia—Methotrexate—breast cancer	9.46e-06	5.88e-05	CcSEcCtD
Fentanyl—Rash—Docetaxel—breast cancer	9.4e-06	5.85e-05	CcSEcCtD
Fentanyl—Hypotension—Epirubicin—breast cancer	9.39e-06	5.84e-05	CcSEcCtD
Fentanyl—Dermatitis—Docetaxel—breast cancer	9.39e-06	5.84e-05	CcSEcCtD
Fentanyl—Confusional state—Doxorubicin—breast cancer	9.38e-06	5.83e-05	CcSEcCtD
Fentanyl—Decreased appetite—Methotrexate—breast cancer	9.34e-06	5.81e-05	CcSEcCtD
Fentanyl—Headache—Docetaxel—breast cancer	9.34e-06	5.81e-05	CcSEcCtD
Fentanyl—Anaphylactic shock—Doxorubicin—breast cancer	9.3e-06	5.79e-05	CcSEcCtD
Fentanyl—Oedema—Doxorubicin—breast cancer	9.3e-06	5.79e-05	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Methotrexate—breast cancer	9.27e-06	5.77e-05	CcSEcCtD
Fentanyl—Fatigue—Methotrexate—breast cancer	9.26e-06	5.76e-05	CcSEcCtD
Fentanyl—Infection—Doxorubicin—breast cancer	9.24e-06	5.75e-05	CcSEcCtD
Fentanyl—Pain—Methotrexate—breast cancer	9.19e-06	5.71e-05	CcSEcCtD
Fentanyl—Vomiting—Capecitabine—breast cancer	9.17e-06	5.71e-05	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Epirubicin—breast cancer	9.16e-06	5.7e-05	CcSEcCtD
Fentanyl—Shock—Doxorubicin—breast cancer	9.15e-06	5.69e-05	CcSEcCtD
Fentanyl—Nervous system disorder—Doxorubicin—breast cancer	9.12e-06	5.67e-05	CcSEcCtD
Fentanyl—Thrombocytopenia—Doxorubicin—breast cancer	9.11e-06	5.67e-05	CcSEcCtD
Fentanyl—Rash—Capecitabine—breast cancer	9.1e-06	5.66e-05	CcSEcCtD
Fentanyl—Insomnia—Epirubicin—breast cancer	9.09e-06	5.66e-05	CcSEcCtD
Fentanyl—Dermatitis—Capecitabine—breast cancer	9.09e-06	5.65e-05	CcSEcCtD
Fentanyl—Tachycardia—Doxorubicin—breast cancer	9.08e-06	5.65e-05	CcSEcCtD
Fentanyl—Headache—Capecitabine—breast cancer	9.04e-06	5.62e-05	CcSEcCtD
Fentanyl—Skin disorder—Doxorubicin—breast cancer	9.03e-06	5.62e-05	CcSEcCtD
Fentanyl—Paraesthesia—Epirubicin—breast cancer	9.03e-06	5.62e-05	CcSEcCtD
Fentanyl—Hyperhidrosis—Doxorubicin—breast cancer	8.99e-06	5.59e-05	CcSEcCtD
Fentanyl—Dyspnoea—Epirubicin—breast cancer	8.96e-06	5.58e-05	CcSEcCtD
Fentanyl—Somnolence—Epirubicin—breast cancer	8.94e-06	5.56e-05	CcSEcCtD
Fentanyl—Anorexia—Doxorubicin—breast cancer	8.87e-06	5.52e-05	CcSEcCtD
Fentanyl—Nausea—Docetaxel—breast cancer	8.85e-06	5.51e-05	CcSEcCtD
Fentanyl—Feeling abnormal—Methotrexate—breast cancer	8.85e-06	5.51e-05	CcSEcCtD
Fentanyl—Dyspepsia—Epirubicin—breast cancer	8.85e-06	5.5e-05	CcSEcCtD
Fentanyl—Gastrointestinal pain—Methotrexate—breast cancer	8.78e-06	5.46e-05	CcSEcCtD
Fentanyl—Decreased appetite—Epirubicin—breast cancer	8.74e-06	5.44e-05	CcSEcCtD
Fentanyl—Hypotension—Doxorubicin—breast cancer	8.69e-06	5.41e-05	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Epirubicin—breast cancer	8.68e-06	5.4e-05	CcSEcCtD
Fentanyl—Fatigue—Epirubicin—breast cancer	8.67e-06	5.39e-05	CcSEcCtD
Fentanyl—Pain—Epirubicin—breast cancer	8.6e-06	5.35e-05	CcSEcCtD
Fentanyl—Constipation—Epirubicin—breast cancer	8.6e-06	5.35e-05	CcSEcCtD
Fentanyl—Nausea—Capecitabine—breast cancer	8.57e-06	5.33e-05	CcSEcCtD
Fentanyl—Urticaria—Methotrexate—breast cancer	8.53e-06	5.31e-05	CcSEcCtD
Fentanyl—Abdominal pain—Methotrexate—breast cancer	8.49e-06	5.28e-05	CcSEcCtD
Fentanyl—Body temperature increased—Methotrexate—breast cancer	8.49e-06	5.28e-05	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Doxorubicin—breast cancer	8.47e-06	5.27e-05	CcSEcCtD
Fentanyl—Insomnia—Doxorubicin—breast cancer	8.41e-06	5.23e-05	CcSEcCtD
Fentanyl—Paraesthesia—Doxorubicin—breast cancer	8.35e-06	5.2e-05	CcSEcCtD
Fentanyl—Dyspnoea—Doxorubicin—breast cancer	8.29e-06	5.16e-05	CcSEcCtD
Fentanyl—Feeling abnormal—Epirubicin—breast cancer	8.28e-06	5.15e-05	CcSEcCtD
Fentanyl—Somnolence—Doxorubicin—breast cancer	8.27e-06	5.14e-05	CcSEcCtD
Fentanyl—Gastrointestinal pain—Epirubicin—breast cancer	8.22e-06	5.11e-05	CcSEcCtD
Fentanyl—Dyspepsia—Doxorubicin—breast cancer	8.19e-06	5.09e-05	CcSEcCtD
Fentanyl—Decreased appetite—Doxorubicin—breast cancer	8.09e-06	5.03e-05	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Doxorubicin—breast cancer	8.03e-06	5e-05	CcSEcCtD
Fentanyl—Fatigue—Doxorubicin—breast cancer	8.02e-06	4.99e-05	CcSEcCtD
Fentanyl—Urticaria—Epirubicin—breast cancer	7.99e-06	4.97e-05	CcSEcCtD
Fentanyl—Pain—Doxorubicin—breast cancer	7.95e-06	4.95e-05	CcSEcCtD
Fentanyl—Constipation—Doxorubicin—breast cancer	7.95e-06	4.95e-05	CcSEcCtD
Fentanyl—Abdominal pain—Epirubicin—breast cancer	7.95e-06	4.94e-05	CcSEcCtD
Fentanyl—Body temperature increased—Epirubicin—breast cancer	7.95e-06	4.94e-05	CcSEcCtD
Fentanyl—Hypersensitivity—Methotrexate—breast cancer	7.91e-06	4.92e-05	CcSEcCtD
Fentanyl—Asthenia—Methotrexate—breast cancer	7.71e-06	4.79e-05	CcSEcCtD
Fentanyl—Feeling abnormal—Doxorubicin—breast cancer	7.66e-06	4.77e-05	CcSEcCtD
Fentanyl—Gastrointestinal pain—Doxorubicin—breast cancer	7.61e-06	4.73e-05	CcSEcCtD
Fentanyl—Pruritus—Methotrexate—breast cancer	7.6e-06	4.73e-05	CcSEcCtD
Fentanyl—Hypersensitivity—Epirubicin—breast cancer	7.41e-06	4.61e-05	CcSEcCtD
Fentanyl—Urticaria—Doxorubicin—breast cancer	7.39e-06	4.6e-05	CcSEcCtD
Fentanyl—Abdominal pain—Doxorubicin—breast cancer	7.35e-06	4.57e-05	CcSEcCtD
Fentanyl—Body temperature increased—Doxorubicin—breast cancer	7.35e-06	4.57e-05	CcSEcCtD
Fentanyl—Diarrhoea—Methotrexate—breast cancer	7.35e-06	4.57e-05	CcSEcCtD
Fentanyl—Asthenia—Epirubicin—breast cancer	7.21e-06	4.49e-05	CcSEcCtD
Fentanyl—Pruritus—Epirubicin—breast cancer	7.11e-06	4.42e-05	CcSEcCtD
Fentanyl—Dizziness—Methotrexate—breast cancer	7.1e-06	4.42e-05	CcSEcCtD
Fentanyl—Diarrhoea—Epirubicin—breast cancer	6.88e-06	4.28e-05	CcSEcCtD
Fentanyl—Hypersensitivity—Doxorubicin—breast cancer	6.85e-06	4.26e-05	CcSEcCtD
Fentanyl—Vomiting—Methotrexate—breast cancer	6.83e-06	4.25e-05	CcSEcCtD
Fentanyl—Rash—Methotrexate—breast cancer	6.77e-06	4.21e-05	CcSEcCtD
Fentanyl—Dermatitis—Methotrexate—breast cancer	6.77e-06	4.21e-05	CcSEcCtD
Fentanyl—Headache—Methotrexate—breast cancer	6.73e-06	4.19e-05	CcSEcCtD
Fentanyl—Asthenia—Doxorubicin—breast cancer	6.67e-06	4.15e-05	CcSEcCtD
Fentanyl—Dizziness—Epirubicin—breast cancer	6.65e-06	4.14e-05	CcSEcCtD
Fentanyl—Pruritus—Doxorubicin—breast cancer	6.58e-06	4.09e-05	CcSEcCtD
Fentanyl—Vomiting—Epirubicin—breast cancer	6.39e-06	3.98e-05	CcSEcCtD
Fentanyl—Nausea—Methotrexate—breast cancer	6.38e-06	3.97e-05	CcSEcCtD
Fentanyl—Diarrhoea—Doxorubicin—breast cancer	6.36e-06	3.96e-05	CcSEcCtD
Fentanyl—Rash—Epirubicin—breast cancer	6.34e-06	3.94e-05	CcSEcCtD
Fentanyl—Dermatitis—Epirubicin—breast cancer	6.33e-06	3.94e-05	CcSEcCtD
Fentanyl—Headache—Epirubicin—breast cancer	6.3e-06	3.92e-05	CcSEcCtD
Fentanyl—Dizziness—Doxorubicin—breast cancer	6.15e-06	3.83e-05	CcSEcCtD
Fentanyl—Nausea—Epirubicin—breast cancer	5.97e-06	3.71e-05	CcSEcCtD
Fentanyl—Vomiting—Doxorubicin—breast cancer	5.91e-06	3.68e-05	CcSEcCtD
Fentanyl—Rash—Doxorubicin—breast cancer	5.86e-06	3.65e-05	CcSEcCtD
Fentanyl—Dermatitis—Doxorubicin—breast cancer	5.86e-06	3.64e-05	CcSEcCtD
Fentanyl—Headache—Doxorubicin—breast cancer	5.83e-06	3.62e-05	CcSEcCtD
Fentanyl—Nausea—Doxorubicin—breast cancer	5.52e-06	3.44e-05	CcSEcCtD
Fentanyl—OPRD1—Signaling by GPCR—PIK3CA—breast cancer	3.51e-06	8.2e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MDM2—breast cancer	3.5e-06	8.17e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—RAF1—breast cancer	3.49e-06	8.14e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ESR1—breast cancer	3.48e-06	8.13e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—RELA—breast cancer	3.47e-06	8.11e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ERBB2—breast cancer	3.45e-06	8.05e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—FN1—breast cancer	3.44e-06	8.03e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CD—breast cancer	3.42e-06	8e-05	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	3.42e-06	7.99e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—FASN—breast cancer	3.42e-06	7.98e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CB—breast cancer	3.4e-06	7.95e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MTOR—breast cancer	3.4e-06	7.95e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—BCHE—breast cancer	3.4e-06	7.94e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NFKBIA—breast cancer	3.4e-06	7.94e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ABCB1—breast cancer	3.4e-06	7.93e-05	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—PIK3CA—breast cancer	3.39e-06	7.92e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SERPINE1—breast cancer	3.39e-06	7.91e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CG—breast cancer	3.39e-06	7.91e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NOTCH1—breast cancer	3.37e-06	7.86e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SLC5A5—breast cancer	3.36e-06	7.85e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—KRAS—breast cancer	3.35e-06	7.83e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTA4—breast cancer	3.34e-06	7.79e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CA9—breast cancer	3.34e-06	7.79e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—TYMS—breast cancer	3.34e-06	7.79e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PLA2G4A—breast cancer	3.3e-06	7.7e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—NCOR1—breast cancer	3.3e-06	7.7e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GSTM1—breast cancer	3.3e-06	7.7e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—KIT—breast cancer	3.29e-06	7.69e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CG—breast cancer	3.29e-06	7.69e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—APC—breast cancer	3.29e-06	7.69e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CXCL8—breast cancer	3.27e-06	7.64e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—EGF—breast cancer	3.25e-06	7.6e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GPX2—breast cancer	3.25e-06	7.6e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTA2—breast cancer	3.25e-06	7.6e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—HRAS—breast cancer	3.25e-06	7.59e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SLC2A1—breast cancer	3.25e-06	7.58e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—NQO1—breast cancer	3.25e-06	7.58e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NOS3—breast cancer	3.23e-06	7.55e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SULT1A1—breast cancer	3.21e-06	7.5e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GPX4—breast cancer	3.21e-06	7.5e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CDKN1B—breast cancer	3.19e-06	7.46e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP3A4—breast cancer	3.17e-06	7.39e-05	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—AKT1—breast cancer	3.16e-06	7.38e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GPX1—breast cancer	3.16e-06	7.37e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—MAPK3—breast cancer	3.15e-06	7.36e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTA1—breast cancer	3.14e-06	7.33e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—IDH1—breast cancer	3.14e-06	7.33e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CASP3—breast cancer	3.13e-06	7.31e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL2—breast cancer	3.13e-06	7.3e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CYP1A1—breast cancer	3.13e-06	7.3e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP1B1—breast cancer	3.11e-06	7.27e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL6—breast cancer	3.11e-06	7.26e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NAT2—breast cancer	3.1e-06	7.25e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ERCC2—breast cancer	3.1e-06	7.24e-05	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	3.1e-06	7.23e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—BRAF—breast cancer	3.09e-06	7.23e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—PIK3CA—breast cancer	3.08e-06	7.19e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MDM2—breast cancer	3.07e-06	7.16e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—RAF1—breast cancer	3.06e-06	7.14e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—HSP90AA1—breast cancer	3.05e-06	7.13e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CCND1—breast cancer	3.05e-06	7.12e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—RELA—breast cancer	3.04e-06	7.11e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—JUN—breast cancer	3.04e-06	7.1e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ERBB2—breast cancer	3.02e-06	7.06e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CTNNB1—breast cancer	3.02e-06	7.05e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IGF1—breast cancer	3.01e-06	7.04e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—AKT2—breast cancer	3.01e-06	7.03e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—EGFR—breast cancer	3e-06	7e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MTOR—breast cancer	2.98e-06	6.97e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CB—breast cancer	2.98e-06	6.97e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CD—breast cancer	2.98e-06	6.95e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—NCOA1—breast cancer	2.97e-06	6.93e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MMP9—breast cancer	2.96e-06	6.91e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CDKN1A—breast cancer	2.95e-06	6.88e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PTEN—breast cancer	2.94e-06	6.87e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ALB—breast cancer	2.94e-06	6.86e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—STK11—breast cancer	2.93e-06	6.83e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP19A1—breast cancer	2.93e-06	6.83e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—MTHFR—breast cancer	2.91e-06	6.8e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CD—breast cancer	2.89e-06	6.76e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MAPK8—breast cancer	2.88e-06	6.72e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—AKT1—breast cancer	2.87e-06	6.7e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CXCL8—breast cancer	2.87e-06	6.7e-05	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—PIK3CA—breast cancer	2.87e-06	6.69e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SERPINE1—breast cancer	2.86e-06	6.68e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—HRAS—breast cancer	2.85e-06	6.65e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—KRAS—breast cancer	2.83e-06	6.62e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—NOS3—breast cancer	2.81e-06	6.56e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CDKN1B—breast cancer	2.8e-06	6.54e-05	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—AKT1—breast cancer	2.77e-06	6.47e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CASP3—breast cancer	2.75e-06	6.41e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL2—breast cancer	2.74e-06	6.4e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NOS3—breast cancer	2.73e-06	6.38e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—SRC—breast cancer	2.73e-06	6.37e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL6—breast cancer	2.73e-06	6.37e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—MED12—breast cancer	2.72e-06	6.35e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—DPYD—breast cancer	2.72e-06	6.35e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—COMT—breast cancer	2.72e-06	6.35e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTP1—breast cancer	2.71e-06	6.32e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CAV1—breast cancer	2.69e-06	6.27e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALDOA—breast cancer	2.68e-06	6.25e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCND1—breast cancer	2.67e-06	6.24e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—HMOX1—breast cancer	2.67e-06	6.23e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—JUN—breast cancer	2.67e-06	6.23e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ITPR1—breast cancer	2.66e-06	6.22e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—VEGFA—breast cancer	2.66e-06	6.2e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CTNNB1—breast cancer	2.65e-06	6.18e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—STAT3—breast cancer	2.63e-06	6.14e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PIK3CA—breast cancer	2.6e-06	6.08e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NCOA3—breast cancer	2.6e-06	6.07e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CB—breast cancer	2.59e-06	6.06e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MMP9—breast cancer	2.59e-06	6.06e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MDM2—breast cancer	2.59e-06	6.05e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CDKN1A—breast cancer	2.59e-06	6.04e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—RAF1—breast cancer	2.58e-06	6.03e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SLC2A2—breast cancer	2.58e-06	6.03e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PTEN—breast cancer	2.58e-06	6.02e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—RELA—breast cancer	2.57e-06	6.01e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PTGS2—breast cancer	2.57e-06	6e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ERBB2—breast cancer	2.56e-06	5.97e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CPT1A—breast cancer	2.53e-06	5.91e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ABCG2—breast cancer	2.53e-06	5.91e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—MTR—breast cancer	2.53e-06	5.91e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MAPK8—breast cancer	2.52e-06	5.89e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CB—breast cancer	2.52e-06	5.89e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MTOR—breast cancer	2.52e-06	5.89e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—TYMS—breast cancer	2.52e-06	5.88e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—AKT1—breast cancer	2.52e-06	5.88e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MAPK3—breast cancer	2.51e-06	5.87e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—NCOR1—breast cancer	2.49e-06	5.81e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTM1—breast cancer	2.49e-06	5.81e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PLA2G4A—breast cancer	2.49e-06	5.81e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HPGDS—breast cancer	2.48e-06	5.79e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HBA1—breast cancer	2.47e-06	5.76e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CG—breast cancer	2.45e-06	5.72e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MYC—breast cancer	2.44e-06	5.71e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TGFB1—breast cancer	2.44e-06	5.69e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CXCL8—breast cancer	2.42e-06	5.66e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—HRAS—breast cancer	2.41e-06	5.62e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTT1—breast cancer	2.41e-06	5.62e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ACHE—breast cancer	2.41e-06	5.62e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SRC—breast cancer	2.39e-06	5.59e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—EGFR—breast cancer	2.39e-06	5.58e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GPX1—breast cancer	2.38e-06	5.56e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CDKN1B—breast cancer	2.37e-06	5.53e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP1A1—breast cancer	2.36e-06	5.51e-05	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—AKT1—breast cancer	2.34e-06	5.47e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ERCC2—breast cancer	2.34e-06	5.46e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—VEGFA—breast cancer	2.33e-06	5.44e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CASP3—breast cancer	2.32e-06	5.42e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL2—breast cancer	2.32e-06	5.41e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—STAT3—breast cancer	2.31e-06	5.39e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL6—breast cancer	2.31e-06	5.38e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP17A1—breast cancer	2.28e-06	5.32e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—KRAS—breast cancer	2.26e-06	5.27e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCND1—breast cancer	2.26e-06	5.27e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTGS1—breast cancer	2.25e-06	5.26e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ENO1—breast cancer	2.25e-06	5.26e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—JUN—breast cancer	2.25e-06	5.26e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PTEN—breast cancer	2.24e-06	5.24e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CTNNB1—breast cancer	2.24e-06	5.22e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP2D6—breast cancer	2.21e-06	5.16e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MAPK3—breast cancer	2.2e-06	5.15e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—MTHFR—breast cancer	2.2e-06	5.13e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MMP9—breast cancer	2.19e-06	5.12e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CDKN1A—breast cancer	2.18e-06	5.1e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PTEN—breast cancer	2.18e-06	5.09e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NCOA2—breast cancer	2.17e-06	5.07e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CD—breast cancer	2.15e-06	5.02e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MYC—breast cancer	2.14e-06	5.01e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TGFB1—breast cancer	2.14e-06	4.99e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MAPK8—breast cancer	2.13e-06	4.98e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—AKT1—breast cancer	2.13e-06	4.97e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ALB—breast cancer	2.12e-06	4.96e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—FASN—breast cancer	2.1e-06	4.91e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—EGFR—breast cancer	2.1e-06	4.9e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—BCHE—breast cancer	2.1e-06	4.89e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CA—breast cancer	2.08e-06	4.85e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SLC5A5—breast cancer	2.07e-06	4.83e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—NOS3—breast cancer	2.03e-06	4.74e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CAV1—breast cancer	2.03e-06	4.74e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SRC—breast cancer	2.02e-06	4.72e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TP53—breast cancer	2.01e-06	4.69e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NQO1—breast cancer	2e-06	4.67e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SLC2A1—breast cancer	2e-06	4.67e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—KRAS—breast cancer	1.98e-06	4.62e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—VEGFA—breast cancer	1.97e-06	4.6e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—STAT3—breast cancer	1.95e-06	4.55e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HRAS—breast cancer	1.92e-06	4.48e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP1B1—breast cancer	1.92e-06	4.48e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.88e-06	4.39e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CB—breast cancer	1.88e-06	4.38e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MAPK3—breast cancer	1.86e-06	4.35e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTGS2—breast cancer	1.86e-06	4.34e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CG—breast cancer	1.85e-06	4.31e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL6—breast cancer	1.84e-06	4.29e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NCOA1—breast cancer	1.83e-06	4.27e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CA—breast cancer	1.82e-06	4.25e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MYC—breast cancer	1.81e-06	4.23e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TGFB1—breast cancer	1.81e-06	4.22e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—STK11—breast cancer	1.8e-06	4.21e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP19A1—breast cancer	1.8e-06	4.21e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—EGFR—breast cancer	1.77e-06	4.14e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TP53—breast cancer	1.76e-06	4.11e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—AKT1—breast cancer	1.7e-06	3.96e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HRAS—breast cancer	1.68e-06	3.93e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—COMT—breast cancer	1.68e-06	3.91e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—KRAS—breast cancer	1.67e-06	3.91e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTP1—breast cancer	1.67e-06	3.89e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HMOX1—breast cancer	1.64e-06	3.84e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ITPR1—breast cancer	1.64e-06	3.83e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CD—breast cancer	1.62e-06	3.79e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTEN—breast cancer	1.62e-06	3.78e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL6—breast cancer	1.61e-06	3.76e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ALB—breast cancer	1.6e-06	3.74e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CA—breast cancer	1.58e-06	3.69e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ABCB1—breast cancer	1.58e-06	3.69e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—TYMS—breast cancer	1.55e-06	3.62e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CA—breast cancer	1.54e-06	3.59e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—NOS3—breast cancer	1.53e-06	3.58e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.53e-06	3.58e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NCOR1—breast cancer	1.53e-06	3.58e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTM1—breast cancer	1.53e-06	3.58e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TP53—breast cancer	1.49e-06	3.47e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—AKT1—breast cancer	1.49e-06	3.47e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GPX1—breast cancer	1.47e-06	3.43e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP1A1—breast cancer	1.45e-06	3.39e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ERCC2—breast cancer	1.44e-06	3.36e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HRAS—breast cancer	1.42e-06	3.32e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CB—breast cancer	1.42e-06	3.3e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTGS2—breast cancer	1.4e-06	3.27e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL6—breast cancer	1.36e-06	3.18e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—MTHFR—breast cancer	1.35e-06	3.16e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—AKT1—breast cancer	1.29e-06	3.02e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—AKT1—breast cancer	1.26e-06	2.93e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CAV1—breast cancer	1.25e-06	2.92e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTEN—breast cancer	1.22e-06	2.86e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CA—breast cancer	1.14e-06	2.67e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CG—breast cancer	1.14e-06	2.66e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CD—breast cancer	1e-06	2.34e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALB—breast cancer	9.88e-07	2.31e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NOS3—breast cancer	9.45e-07	2.21e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—AKT1—breast cancer	9.34e-07	2.18e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CB—breast cancer	8.72e-07	2.04e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTGS2—breast cancer	8.64e-07	2.02e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CA—breast cancer	8.63e-07	2.01e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTEN—breast cancer	7.54e-07	1.76e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—AKT1—breast cancer	7.05e-07	1.65e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CA—breast cancer	5.32e-07	1.24e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—AKT1—breast cancer	4.34e-07	1.01e-05	CbGpPWpGaD
